Apoptosis in cancer: implications for therapy
Resistance towards apoptosis is a key factor for the survival of a malignant cell. Cancer results if there is too little apoptosis and cells grow faster and live longer than normal cells. In addition, defects in apoptosis signaling contribute to drug resistance of tumor cells. Thus, one of the main...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
1 October 2005
|
| In: |
Seminars in oncology
Year: 2004, Volume: 31, Issue: 1, Pages: 90-119 |
| ISSN: | 1532-8708 |
| DOI: | 10.1053/j.seminoncol.2003.11.006 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1053/j.seminoncol.2003.11.006 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0093775403005682 
|
| Author Notes: | Henning Schulze-Bergkamen, Peter H Krammer |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1750136147 | ||
| 003 | DE-627 | ||
| 005 | 20220819123559.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210302r20052004xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1053/j.seminoncol.2003.11.006 |2 doi | |
| 035 | |a (DE-627)1750136147 | ||
| 035 | |a (DE-599)KXP1750136147 | ||
| 035 | |a (OCoLC)1341396505 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schulze-Bergkamen, Henning |d 1971- |e VerfasserIn |0 (DE-588)120914387 |0 (DE-627)080966403 |0 (DE-576)292444907 |4 aut | |
| 245 | 1 | 0 | |a Apoptosis in cancer |b implications for therapy |c Henning Schulze-Bergkamen, Peter H Krammer |
| 264 | 1 | |c 1 October 2005 | |
| 300 | |a 30 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 02.03.2021 | ||
| 520 | |a Resistance towards apoptosis is a key factor for the survival of a malignant cell. Cancer results if there is too little apoptosis and cells grow faster and live longer than normal cells. In addition, defects in apoptosis signaling contribute to drug resistance of tumor cells. Thus, one of the main goals for oncologic treatment is to overcome resistance of tumor cells towards apoptosis. The exciting challenge in oncology is to translate the growing knowledge of apoptotic pathways into clinical applications. In this review we address the role of apoptosis signaling in tumorigenesis and drug resistance of tumor cells and discuss therapeutic approaches interfering with apoptosis pathways. | ||
| 534 | |c 2004 | ||
| 700 | 1 | |a Krammer, Peter H. |d 1946- |e VerfasserIn |0 (DE-588)121766373 |0 (DE-627)081520255 |0 (DE-576)292873417 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Seminars in oncology |d Amsterdam [u.a.] : Elsevier, 2001 |g 31(2004), 1 vom: Feb., Seite 90-119 |h Online-Ressource |w (DE-627)34306247X |w (DE-600)2073537-6 |w (DE-576)099718340 |x 1532-8708 |7 nnas |a Apoptosis in cancer implications for therapy |
| 773 | 1 | 8 | |g volume:31 |g year:2004 |g number:1 |g month:02 |g pages:90-119 |g extent:30 |a Apoptosis in cancer implications for therapy |
| 856 | 4 | 0 | |u https://doi.org/10.1053/j.seminoncol.2003.11.006 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0093775403005682 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210302 | ||
| 993 | |a Article | ||
| 994 | |a 2004 | ||
| 998 | |g 121766373 |a Krammer, Peter H. |m 121766373:Krammer, Peter H. |d 50000 |e 50000PK121766373 |k 0/50000/ |p 2 |y j | ||
| 998 | |g 120914387 |a Schulze-Bergkamen, Henning |m 120914387:Schulze-Bergkamen, Henning |d 50000 |e 50000PS120914387 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1750136147 |e 3880084548 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Schulze-Bergkamen, Henning","given":"Henning","family":"Schulze-Bergkamen"},{"display":"Krammer, Peter H.","roleDisplay":"VerfasserIn","role":"aut","family":"Krammer","given":"Peter H."}],"title":[{"title_sort":"Apoptosis in cancer","subtitle":"implications for therapy","title":"Apoptosis in cancer"}],"note":["Gesehen am 02.03.2021"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1750136147","language":["eng"],"name":{"displayForm":["Henning Schulze-Bergkamen, Peter H Krammer"]},"origin":[{"dateIssuedDisp":"1 October 2005","dateIssuedKey":"2005"}],"id":{"doi":["10.1053/j.seminoncol.2003.11.006"],"eki":["1750136147"]},"physDesc":[{"extent":"30 S."}],"relHost":[{"origin":[{"publisherPlace":"Amsterdam [u.a.] ; Philadelphia, Pa.","dateIssuedDisp":"2001-","dateIssuedKey":"2001","publisher":"Elsevier ; Saunders"}],"id":{"zdb":["2073537-6"],"eki":["34306247X"],"issn":["1532-8708"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Seminars in oncology","title":"Seminars in oncology"}],"pubHistory":["Nachgewiesen 28.2001 -"],"part":{"year":"2004","issue":"1","pages":"90-119","text":"31(2004), 1 vom: Feb., Seite 90-119","volume":"31","extent":"30"},"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 24.06.25"],"disp":"Apoptosis in cancer implications for therapySeminars in oncology","recId":"34306247X","language":["eng"]}]} | ||
| SRT | |a SCHULZEBERAPOPTOSISI1200 | ||